In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
about
Antibody-drug conjugates as novel anti-cancer chemotherapeuticsAntibody Therapeutics in Oncology.ADME of antibody-maytansinoid conjugatesNew Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats.Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates.
P2860
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@ast
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@en
type
label
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@ast
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@en
prefLabel
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@ast
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@en
P2860
P356
P1476
In vivo behaviour of antibody-drug conjugates for the targeted treatment of cancer.
@en
P2093
Hongsheng Xie
Walter A Blättler
P2860
P304
P356
10.1517/14712598.6.3.281
P407
P577
2006-03-01T00:00:00Z